Gorbachev Anton V, Fairchild Robert L
Department of Immunology, Cleveland Clinic, Cleveland, OH, 44195.
Department of Immunology and Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 and Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Crit Rev Immunol. 2014;34(2):103-20. doi: 10.1615/critrevimmunol.2014010062.
Chemokines are chemotactic cytokines critical for homeostatic and inflammation-induced trafficking of leukocytes during immune responses, hematopoesis, wound healing, and tumorigenesis. Despite three decades of intensive study of the chemokine network, the molecular mechanisms regulating chemokine expression during tumor growth are not well understood. In this review, we focus on the role of chemokines in both tumor growth and anti-tumor immune responses and on molecular mechanisms employed by tumor cells to regulate chemokine expression in the tumor microenvironment. Multiple mechanisms used by tumors to regulate chemokine production, including those revealed by very recent studies (such as DNA methylation or post-translational nitrosylation of chemokines) are discussed. Concluding the review, we discuss how understanding of these regulatory mechanisms can be used in cancer therapy to suppress tumor growth and/or to promote immune-mediated eradication of tumors.
趋化因子是一类趋化性细胞因子,在免疫反应、造血、伤口愈合和肿瘤发生过程中,对白细胞的稳态和炎症诱导的运输至关重要。尽管对趋化因子网络进行了三十年的深入研究,但在肿瘤生长过程中调节趋化因子表达的分子机制仍未得到充分理解。在这篇综述中,我们重点关注趋化因子在肿瘤生长和抗肿瘤免疫反应中的作用,以及肿瘤细胞在肿瘤微环境中调节趋化因子表达所采用的分子机制。我们讨论了肿瘤用于调节趋化因子产生的多种机制,包括最近的研究揭示的机制(如趋化因子的DNA甲基化或翻译后亚硝化)。在综述结尾,我们讨论了如何利用对这些调节机制的理解来进行癌症治疗,以抑制肿瘤生长和/或促进免疫介导的肿瘤根除。